Free press releases distribution network?

Agency / Source: Phillips DiPisa

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Basilea Pharmaceuticals, Inc. Appoints National Sales Director - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug
Basilea Pharmaceuticals, Inc. Appoints National Sales Director

 

PRZOOM - /newswire/ - Hingham, MA, United States, 2007/10/09 - Phillips DiPisa completes a search assignment for Basilea Pharmaceuticals, Inc. Company appoints Ken Farah as National Sales Director for its Ceftobiprole drug.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Phillips DiPisa, a retained executive search firm serving healthcare providers, managed care organizations, and life sciences firms, today announced that it has completed an executive search assignment for Basilea Pharmaceuticals, Inc.

Basilea Pharmaceuticals, Inc., a newly launched U.S. subsidiary of Switzerland's Basilea Pharmaceutica, hired Ken Farah as the National Sales Director. Phillips DiPisa led the search on behalf of Basilea Pharmaceuticals.

At Basilea, Farah will lead the company’s first sales team for Ceftobiprole, which is awaiting FDA approval to treat methicillin-resistant staff infections.

Farah has over 25 years of sales and sales management experience launching specialty anti-infective and oncology products in the hospital markets. Most recently, Farah was a Sales Director for Dendreon Corporation. Prior, he managed regions around the country for Ortho McNeil/Alza, where he helped build the specialty sales force for the ADHD drug Concerta.

Farah also served at ALZA, Sequus and Immunex, in capacities such as Regional Manager, Director of Strategic Oncology accounts and Oncology Account Executive. He began his career in sales at Lederle, where he rose to management in the hospital division and concentrated on antibiotic sales in the hospital marketplace.

Basilea Pharmaceutica Ltd. is a biopharmaceutical company focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea’s products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio, including three investigational phase III drugs of which two have shown positive pivotal phase III results.

Kevin Carroll was Phillips DiPisa’s associate responsible for this engagement.

About Phillips DiPisa

Phillips DiPisa (phillipsdipisa.com) recruits leaders for healthcare providers, managed care organizations, and life sciences firms. The firm’s roots are in Greater Boston – a historical center of medical innovation and excellence. Phillips DiPisa now serves clients along the East Coast and throughout the Midwest, and draws on a national pool of candidates.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Phillips DiPisa

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Basilea Pharmaceuticals, Inc. Appoints National Sales Director

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Beth Mills - PhillipsDiPisa.com 
781-740-9699 bamills[.]phillipsdipisa.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Phillips DiPisa securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Phillips DiPisa / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com

Visit  RightITnow Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today